bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • CRISPR Therapeutics AG logo

    CRISPR Therapeutics AG

    CRSP | NASDAQ
    Chart Builder DCF Calculator
    $51.40
    -$2.86 (-5.27%)
    At close: Oct 30, 2026, 3:59 PM ET
    $51.75
    +$0.35 (+0.68%)
    Pre-market: Nov 2, 2026, 9:07 AM ET

    Market Data

    Market Cap
    $4.97B
    Enterprise Value
    $3.39B
    Beta
    1.76
    Average Volume
    1.6M
    Shares Outstanding (Diluted)
    96.51M
    Shares Change YoY
    10.85%
    Institutional Ownership
    80.19%
    Exchange
    NASDAQ
    ISIN
    CH0334081137

    Price Performance

    Price Change 1M
    -7.1%
    Price Change 3M
    7.1%
    Price Change 6M
    -0.5%
    Price Change YTD
    -2.0%
    Price Change 1Y
    -19.7%
    Price Change 3Y
    32.0%
    Price Change 5Y
    -43.7%
    1M CAGR (ann.)
    -9.1%
    1Y CAGR (ann.)
    -17.8%
    5Y CAGR (ann.)
    -11.7%
    All-Time CAGR
    10.9%

    Valuation

    PE Ratio
    -10.80
    Forward PE
    N/A
    PEG Ratio
    -2.40
    Forward PEG
    0.36
    PS Ratio
    371.12
    Forward PS
    35.90
    PB Ratio
    2.85
    P/FCF Ratio
    -10.34
    P/Adj. FCF Ratio
    -9.05
    P/OCF Ratio
    -13.42
    EV/Sales
    253.09
    EV/EBIT
    -7.17
    EV/EBITDA
    -7.47
    EV/FCF
    -7.05
    Earnings Yield
    -9.3%
    FCF Yield
    -9.7%
    Adj. FCF Yield
    -11.1%

    Financial Health

    Net Cash
    $1.78B
    Total Debt
    $783.75M
    Cash & Short-Term Investments
    $2.36B
    Total Assets
    $2.65B
    Current Ratio
    17.85
    Quick Ratio
    17.85
    Debt / Equity Ratio
    0.45
    Debt / EBITDA
    -1.73
    Debt / FCF
    -1.63
    OCF / Debt
    -0.61
    Interest Coverage
    0.00
    Altman Z-Score
    2.59
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    -1534.4%
    Operating Profit Margin
    -3971.5%
    EBITDA Margin
    -3390.2%
    Net Profit Margin
    -3368.7%
    FCF Margin
    -3589.7%
    Adj. FCF Margin
    -4099.8%
    SBC / Revenue
    510.2%
    SBC Impact (per share)
    -14.2%

    Returns

    Return on Assets
    -17.0%
    Return on Equity
    -24.4%
    Return on Invested Capital
    -21.0%
    Return on Capital Employed
    -21.1%
    Return on Tangible Assets
    -17.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -57.1%
    Revenue CAGR 5Y
    -56.9%
    Revenue CAGR 10Y
    24.3%
    EPS CAGR 3Y
    -17.1%
    EPS CAGR 5Y
    12.6%
    EPS CAGR 10Y
    -17.9%
    FCF CAGR 3Y
    -57.1%
    FCF CAGR 5Y
    2.9%
    FCF CAGR 10Y
    -29.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    11
    EPS Growth Next 3Y
    64.3%
    Revenue Growth Next 3Y
    481.0%
    Earnings Date
    Nov 9, 2026
    EPS Estimate (next Q)
    -$1.04
    EPS Growth Est (next Q)
    -11.1%
    Revenue Est (next Q)
    $14.75M
    Revenue Growth Est (next Q)
    1559.4%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $63.17
    Price Target Upside
    22.9%

    Cash Flow

    Operating Cash Flow
    $-478.48M
    Free Cash Flow
    $-480.73M
    Adj. Free Cash Flow
    $-549.05M
    FCF Per Share
    -$3.87
    OCF Per Share
    -$3.83
    OCF/S Ratio
    -2759.7%

    Income Statement

    Revenue
    $13.39M
    Gross Profit
    $-205.49M
    Operating Income
    $-531.87M
    EBITDA
    $-454M
    Net Income
    $-451.14M
    EPS (Diluted)
    -$4.76
    Revenue / Employee
    $34.08K
    Profit / Employee
    $-1.15M
    Employees
    393

    © 2026 bestshares.com. All rights reserved.

    All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.